Filer Snapshot

Nuveen NASDAQ 100 Dynamic Overwrite Fund

CIK 0001608741. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

14

Latest filing

23 Feb 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Forms 3/4/5

3 filed on 23 Feb 2026 for CIK 0001608741.

View source filing
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
333 West Wacker Drive, Chicago, IL, 60606
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Incorporated in
MA
Fiscal year end
31 December

Filer intelligence

What SEC filings say about Nuveen NASDAQ 100 Dynamic Overwrite Fund

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

No XML rows yet
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

No parsed ownership summary yet

We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.

SEC filing record

CIK 0001608741 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
14
First seen
07 Jul 2021
Latest filing
23 Feb 2026
Entity
Company

Latest Filings

Showing the latest 12 of 14 SEC filings for Nuveen NASDAQ 100 Dynamic Overwrite Fund.

3

3 filing

Filing date
23 Feb 2026
Reporting date
16 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2025
Reporting date
10 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Jul 2025
Reporting date
30 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Dec 2024
Reporting date
02 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Jun 2024
Reporting date
18 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
11 Mar 2024
Reporting date
28 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Mar 2024
Reporting date
28 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Jan 2024
Reporting date
01 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
15 Aug 2022
Reporting date
04 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
08 Jun 2022
Reporting date
01 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
21 Apr 2022
Reporting date
14 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .